Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database
- PMID: 27861763
- DOI: 10.1002/cncr.30405
Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database
Abstract
Background: Atypical teratoid rhabdoid tumors (ATRTs) are rare brain tumors that occur primarily in children under the age of 3 years. This report evaluates the treatment approach and survival outcomes in a large cohort of patients treated in the United States.
Methods: Using the National Cancer Database, the analysis included all ATRT patients aged 0 to 18 years who were diagnosed between 2004 and 2012 and had complete treatment data.
Results: Three hundred sixty-one ATRT patients were evaluated. The 5-year overall survival (OS) rate was 29.9%, and it was significantly lower for children who were less than 3 years old (5-year OS, 27.7%) versus those who were 3 years old or older (5-year OS, 37.5%; P < .001). The best outcome was seen for patients with localized disease who received trimodality therapy (surgery, chemotherapy, and radiation therapy [RT]) with a 5-year OS rate of 46.8%. The utilization of trimodality therapy significantly increased during the study period (27.7% in 2004-2008 vs 45.1% in 2009-2012; P < .01), largely because of the increased use of RT. In a multivariate analysis, treatment that did not utilize trimodality therapy was associated with significantly worse OS (hazard ratio, 2.52; 95% confidence interval (1.82-3.51). Children aged 0 to 2 years were significantly less likely to receive trimodality therapy because of decreased utilization of RT in this age group.
Conclusions: The use of trimodality therapy significantly increased during the study period and was associated with improved outcomes. For patients with localized disease who received trimodality therapy, the OS rate at 5 years approached 50%. However, further research into the optimal management of children less than 3 years old is needed because of their significantly worse OS in comparison with older children. Cancer 2017;123:682-687. © 2016 American Cancer Society.
Keywords: National Cancer Database (NCDB); atypical teratoid rhabdoid tumor (ATRT); pediatric oncology.
© 2016 American Cancer Society.
Similar articles
-
Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.Cancer Med. 2014 Feb;3(1):91-100. doi: 10.1002/cam4.161. Epub 2013 Dec 11. Cancer Med. 2014. PMID: 24402832 Free PMC article.
-
Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis.Pediatr Blood Cancer. 2019 Dec;66(12):e27969. doi: 10.1002/pbc.27969. Epub 2019 Aug 28. Pediatr Blood Cancer. 2019. PMID: 31464041
-
Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.J Pediatr Hematol Oncol. 2009 Sep;31(9):651-63. doi: 10.1097/MPH.0b013e3181b258a9. J Pediatr Hematol Oncol. 2009. PMID: 19707161
-
Management of Atypical Teratoid/Rhabdoid Tumors in the Pediatric Population: A Systematic Review and Meta-Analysis.World Neurosurg. 2024 Jan;181:e504-e515. doi: 10.1016/j.wneu.2023.10.089. Epub 2023 Oct 21. World Neurosurg. 2024. PMID: 37871692
-
Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy.J Neurooncol. 2007 Jan;81(1):97-111. doi: 10.1007/s11060-006-9196-z. Epub 2006 Jul 20. J Neurooncol. 2007. PMID: 16855864 Review.
Cited by
-
Atypical teratoid rhabdoid tumours (ATRTs)-a 21-year institutional experience.Childs Nerv Syst. 2023 Jun;39(6):1509-1518. doi: 10.1007/s00381-023-05828-0. Epub 2023 Feb 15. Childs Nerv Syst. 2023. PMID: 36790496
-
Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.Neurosurg Rev. 2020 Feb;43(1):281-292. doi: 10.1007/s10143-018-1055-9. Epub 2018 Dec 8. Neurosurg Rev. 2020. PMID: 30535934
-
Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single-institution study with molecular correlation.Pediatr Blood Cancer. 2024 Oct;71(10):e31208. doi: 10.1002/pbc.31208. Epub 2024 Jul 21. Pediatr Blood Cancer. 2024. PMID: 39034595
-
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors.Cancer Res. 2019 May 1;79(9):2404-2414. doi: 10.1158/0008-5472.CAN-18-3066. Epub 2019 Feb 12. Cancer Res. 2019. PMID: 30755442 Free PMC article.
-
Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients.Childs Nerv Syst. 2018 Apr;34(4):627-638. doi: 10.1007/s00381-017-3688-3. Epub 2017 Dec 7. Childs Nerv Syst. 2018. PMID: 29218405
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources